GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE

被引:66
|
作者
BEUTLER, E
DEMINA, A
GELBART, T
机构
[1] Scripps Research Institute, La Jolla, 92037, California
关键词
D O I
10.1007/bf03403534
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Thirty-six mutations that cause Gaucher disease, the most common glycolipid storage disorder, are known. Although both alleles of most patients with the disease contain one of these mutations, in a few patients one or both disease-producing alleles have remained unidentified. Identification of mutations in these patients is useful for genetic counseling. Materials and Methods: The DNA from 23 Gaucher disease patients in whom at least one glucocerebrosidase allele did not contain any of the 36 previously described mutations has been examined by single strand conformation polymorphism (SSCP) analysis, followed by sequencing of regions in which abnormalities were detected. Results: Eight previously undescribed mutations were detected. In exon 3, a deletion of a cytosine at cDNA nt 203 was found. In exon 6, three missense mutations were identified: a C --> A transversion at cDNA nt 644 (Ala(176) --> Asp), a C --> A transversion at cDNA nt 661 that resulted in a (Pro(182) --> Thr) and a G --> A transition at cDNA nt 721 (Gly(202) --> Arg). Two missense mutations were found in exon 7: a G --> A transition at cDNA nt 887 (Arg(257) --> Gln) and a C --> T at cDNA nt 970 (Arg(285) --> Cys). Two missense mutations were found in exon 9: a T --> G at cDNA nt 1249 (Trp(378) --> Gly) and a G --> A at cDNA nt 1255 (Asp(380) --> Asn). In addition to these disease-producing mutations, a silent C --> G transversion at cDNA nt 1431, occurring in a gene that already contained the 1226G mutation, was found in one family. Conclusions: The mutations described here and previously known can be classified as mild, severe, or lethal, on the basis of their effect on enzyme production and on clinical phenotype, and as polymorphic or sporadic, on the basis of the haplotype in which they are found. Rare mutations such as the new ones described here are sporadic in nature.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 50 条
  • [41] Cultured Macrophage Models for the Investigation of Lysosomal Glucocerebrosidase and Gaucher Disease
    Louwerse, Max
    Bila, Kateryna O.
    van der Lienden, Martijn J. C.
    de Beaufort, Arnout Jan M.
    Boot, Rolf G.
    Artola, Marta
    van Eijk, Marco
    Aerts, Johannes M. F. G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [42] Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers With and Without Parkinson Disease
    Galper, Jasmin
    Balwani, Manisha
    Fahn, Stanley
    Waters, Cheryl
    Krohn, Lynne
    Gan-Or, Ziv
    Dzamko, Nicolas
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2021, 36 (06) : 1451 - 1455
  • [43] Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients
    Ron, Idit
    Horowitz, Mia
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (04) : 426 - 436
  • [44] Mutation spectrum of glucocerebrosidase gene in Pakistani patients with Gaucher disease
    Cheema, Huma A.
    Anjum, Muhammad N.
    Saeed, Anjum
    Zahoor, Muhammad Yasir
    Waheed, Nadia
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S39 - S39
  • [45] Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease
    Schmitz, M
    Alfalah, M
    Aerts, JMFG
    Naim, HY
    Zimmer, KP
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (11): : 2310 - 2320
  • [46] ISOLATION OF AN ACTIVATOR PROTEIN FOR GLUCOCEREBROSIDASE IN CONTROL AND GAUCHER DISEASE BRAIN
    WENGER, DA
    ROTH, S
    BIOCHEMISTRY INTERNATIONAL, 1982, 5 (06): : 705 - 710
  • [47] Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells
    Siebert, Marina
    Westbroek, Wendy
    Chen, Yu-Chi
    Moaven, Nima
    Li, Yan
    Velayati, Arash
    Saraiva-Pereira, Maria Luiza
    Martin, Scott E.
    Sidransky, Ellen
    RNA BIOLOGY, 2014, 11 (10) : 1291 - 1300
  • [48] MODIFYING EXOGENOUS GLUCOCEREBROSIDASE FOR EFFECTIVE REPLACEMENT THERAPY IN GAUCHER DISEASE
    BRADY, RO
    MURRAY, GJ
    BARTON, NW
    JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (04) : 510 - 519
  • [49] Chaperoning glucocerebrosidase:a therapeutic strategy for both Gaucher disease and Parkinsonism
    Benjamin McMahon
    Elma Aflaki
    Ellen Sidransky
    Neural Regeneration Research, 2016, 11 (11) : 1760 - 1761
  • [50] IDENTIFICATION OF GAUCHER DISEASE CARRIERS - GLUCOCEREBROSIDASE ANTIGEN AND DNA ANALYSIS
    LACERDA, L
    AMARAL, O
    PINTO, R
    AERTS, J
    MIRANDA, MCS
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 50 (02): : 190 - 196